Spironolactone improves angiotensin-induced vascular changes and oxidative stress

被引:336
作者
Virdis, A [1 ]
Neves, MF [1 ]
Amiri, F [1 ]
Viel, E [1 ]
Touyz, RM [1 ]
Schiffrin, EL [1 ]
机构
[1] Univ Montreal, Multidisciplinary Res Grp Hypertens, Clin Res Inst Montreal, Montreal, PQ H2W 1R7, Canada
关键词
aldosterone; angiotensin II; endothelium; hypertension; arterial; oxidative stress; remodeling; rats;
D O I
10.1161/01.HYP.0000034738.79310.06
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Angiotensin II plays an important role in vascular remodeling. We investigated the role of aldosterone, which is stimulated by angiotensin II, as a mediator of angiotensin II-induced vascular structural and functional alterations. Sprague-Dawley rats (n=8 to 12/group) received angiotensin II (120 ng/kg per minute, subcutaneously) for 14 days spironolactone or hydralazine (25 mg/kg per day). An additional group received aldosterone (750 ng/h, subcutaneously) +/- spironolactone. Systolic blood pressure was increased by angiotensin II (P<0.001) and reduced by spironolactone and hydralazine (P<0.001). Aldosterone-induced increase of blood pressure was reduced by spironolactone (P<0.05). In mesenteric small arteries studied on a pressurized myograph, media/lumen ratio was increased (P<0.001) and acetylcholine-mediated relaxation was impaired in angiotensin II-infused rats (P<0.001); both were partially improved by spironolactone (P<0.05) but not by hydralazine. Aldosterone-induced increase of media/lumen ratio (P<0.001) and impaired response to acetylcholine (P<0.001) were normalized by spironolactone. Response to sodium nitroprusside was similar in all groups. Aortic NADPH oxidase activity was increased (P<0.01) by angiotensin II and reduced by spironolactone and hydralazine. Aldosterone also increased (P<0.05) activation of NADPH oxidase, an effect abolished by spironolactone. Plasma thiobarbituric acid-reactive substances (a marker of oxidative stress), higher in angiotensin II and aldosterone rats (P<0.001), were normalized by spironolactone. In conclusion, spironolactone, which inhibited aldosterone actions, partially corrected structural and functional angiotensin II-induced abnormalities. These effects were associated with reduced vascular NADPH oxidase activity and decreased plasma markers of oxidative stress. Our findings suggest that aldosterone may mediate some of angiotensin II-induced vascular effects in hypertension, in part via increased oxidative stress.
引用
收藏
页码:504 / 510
页数:7
相关论文
共 41 条
  • [31] SCHRIFFRIN EL, 1984, AM J PHYSIOL-HEART C, V246, pH608
  • [32] Angiotensin II induces vascular smooth muscle cell replication independent of blood pressure
    Su, EJ
    Lombardi, DM
    Siegal, J
    Schwartz, SM
    [J]. HYPERTENSION, 1998, 31 (06) : 1331 - 1337
  • [33] VASODILATION TO ACETYLCHOLINE IN PRIMARY AND SECONDARY FORMS OF HUMAN HYPERTENSION
    TADDEI, S
    VIRDIS, A
    MATTEI, P
    SALVETTI, A
    [J]. HYPERTENSION, 1993, 21 (06) : 929 - 933
  • [34] Regulation of aldosterone synthase in human vascular endothelial cells by angiotensin II and adrenocorticotropin
    Takeda, Y
    Miyamori, I
    Yoneda, T
    Hatakeyama, H
    Inaba, S
    Furukawa, K
    Mabuchi, H
    Takeda, R
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (08) : 2797 - 2800
  • [35] Oxidative stress and vascular damage in hypertension
    Touyz R.M.
    [J]. Current Hypertension Reports, 2000, 2 (1) : 98 - 105
  • [36] p38 MAP kinase regulates vascular smooth muscle cell collagen synthesis by angiotensin II in SHR but not in WKY
    Touyz, RM
    He, G
    El Mabrouk, M
    Schiffrin, EL
    [J]. HYPERTENSION, 2001, 37 (02) : 574 - 580
  • [37] Touyz RM, 2000, PHARMACOL REV, V52, P639
  • [38] ALDOSTERONE ENHANCES ANGIOTENSIN-II RECEPTOR-BINDING AND INOSITOL PHOSPHATE RESPONSES
    ULLIAN, ME
    SCHELLING, JR
    LINAS, SL
    [J]. HYPERTENSION, 1992, 20 (01) : 67 - 73
  • [39] Potentiation of angiotensin II action by corticosteroids in vascular tissue
    Ullian, ME
    Walsh, LG
    Morinelli, TA
    [J]. CARDIOVASCULAR RESEARCH, 1996, 32 (02) : 266 - 273
  • [40] VANHOUTTE PM, 1990, ENDOTHELIUM-DERIVED CONTRACTING FACTORS, P1